Last updated on March 2019

A Phase 3 clinical study for patients with Brain Injury


Brief description of study

There is no AED or medication that has been demonstrated to affect the development of post-traumatic epilepsy. Biperiden is a cholinergic antagonist, acting in the muscarinic receptor, that is widely used as an anti Parkinson drug. The investigators data with animal models of epilepsy indicate that anti-muscarinic agents might affect the natural course of the disease in the case of post-traumatic epilepsy.

Clinical Study Identifier: NCT01048138

Find a site near you

Start Over